Filtros de búsqueda

Lista de obras de Federica Cavallo

2011: the immune hallmarks of cancer

artículo científico publicado en 2011

2H,3H-decafluoropentane-based nanodroplets: new perspectives for oxygen delivery to hypoxic cutaneous tissues

artículo científico publicado en 2015

5th European conference on Progress in Vaccination Against Cancer. 20-21 September 2005, Athens, Greece

artículo científico publicado en 2005

A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters.

artículo científico publicado en 2011

A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth

artículo científico publicado en 2006

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.

artículo científico publicado en 2017

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

artículo científico publicado en 2010

A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions

artículo científico publicado en 2011

A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model

artículo científico publicado en 2016

A mathematical-biological joint effort to investigate the tumor-initiating ability of Cancer Stem Cells

artículo científico publicado en 2014

A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer

artículo científico publicado en 2016

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients ⬇️

artículo científico publicado el 15 de octubre de 2010

An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention

artículo científico publicado en 2005

Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis

artículo científico publicado en 2016

Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas.

artículo científico publicado en 2005

Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors

artículo científico publicado en 2010

Antitumor immunization of mothers delays tumor development in cancer-prone offspring.

artículo científico publicado en 2015

Are oncoantigens suitable targets for anti-tumour therapy?

artículo científico publicado en 2007

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

artículo científico publicado en 2011

Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer

artículo científico publicado en 2011

Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies

artículo científico publicado en 2010

Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

artículo científico publicado en 2018

Autologous transplantation and maintenance therapy in multiple myeloma

artículo científico publicado en 2014

Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide

artículo científico publicado en 2005

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results.

artículo científico publicado en 2013

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

artículo científico publicado en 2007

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancer

artículo científico publicado en 2015

Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells

artículo científico publicado en 2018

CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA

scientific article published on 29 May 2014

Cancer stem cell based adjuvant for oncoantingen-driven vaccination

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

artículo científico publicado en 2014

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

scientific article published on 10 August 2011

Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance

Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients.

artículo científico publicado en 2014

Chondroitin sulfate proteoglycan-4: A biomarker and a potential immunotherapeutic target for canine malignant melanoma

artículo científico publicado en 2011

Classification of current anticancer immunotherapies

artículo científico publicado en 2014

Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment.

artículo científico publicado en 2015

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

artículo científico publicado en 1995

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

artículo científico publicado en 2001

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

artículo científico publicado en 2011

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

article

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

artículo científico publicado en 2015

Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten

artículo científico publicado en 2010

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.

artículo científico publicado en 2015

Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma

artículo científico publicado en 2018

Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity

artículo científico publicado en 2005

Current treatment strategies with lenalidomide in multiple myeloma and future perspectives.

artículo científico publicado en 2012

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

artículo científico publicado en 2005

DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice

artículo científico publicado en 2007

DNA vaccination against membrane-bound Kit ligand: a new approach to inhibiting tumour growth and angiogenesis

artículo científico publicado en 2013

DNA vaccination against oncoantigens: A promise

artículo científico publicado en 2012

DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma

article

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer

artículo científico publicado en 2020

Digging in the RNA-seq Garbage: Evaluating the Characteristics of Unmapped RNA-seq Reads in Normal Tissues

scholarly article published July 2012

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

scientific article published on 12 September 2013

Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.

artículo científico publicado en 2015

Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma

artículo científico publicado en 2004

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

artículo científico publicado en 2004

ErbB2 receptor over-expression improves post-traumatic peripheral nerve regeneration in adult mice

artículo científico publicado en 2013

Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy.

artículo científico publicado en 2010

Fifth European progress in vaccination against cancer conference, PIVAC 5

artículo científico publicado en 2006

From exogenous cytokines to gene therapy: cytokine activated tumor inhibition.

artículo científico publicado en 1992

Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.

artículo científico publicado en 2016

Have drug combinations supplanted stem cell transplantation in myeloma?

artículo científico

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

artículo científico publicado en 2012

Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.

artículo científico publicado en 2014

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.

artículo científico publicado en 2005

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas

scientific article published on 06 April 2020

Immunological prevention of spontaneous tumors: a new prospect?

scientific article published on 01 February 2002

Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine

artículo científico publicado en 2004

Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance

artículo científico publicado en 2006

Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer

artículo científico publicado en 2015

Immunotargeting of the xCT cystine/glutamate antiporter potentiates the efficacy of Her2-targeted immunotherapies in breast cancer

artículo científico publicado en 2020

Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice

artículo científico publicado en 2007

Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies

artículo científico publicado en 2013

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL

artículo científico publicado en 2019

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

artículo científico publicado en 1998

Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma

scientific article published on 01 May 2006

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

scientific article published on 20 July 2004

Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice

artículo científico publicado en 2008

Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells

artículo científico publicado en 2014

Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.

artículo científico publicado en 2006

Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

artículo científico publicado en 2016

L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents.

artículo científico publicado en 2016

Lenalidomide and its role in the management of multiple myeloma

artículo científico publicado en 2008

Lenalidomide in the treatment of plasma cell dyscrasia: state of the art and perspectives.

artículo científico publicado en 2013

Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients

scientific article published on 21 September 2012

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

artículo científico publicado en 2014

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

artículo científico publicado en 2014

Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

artículo científico publicado en 2009

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

artículo científico publicado en 2010

Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth

artículo científico

Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice

artículo científico publicado en 2014

Multi-level model for the investigation of oncoantigen-driven vaccination effect

artículo científico publicado en 2013

Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))

artículo científico publicado en 2004

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.

artículo científico publicado en 2014

Murine pneumotropic virus chimeric Her2/neu virus-like particles as prophylactic and therapeutic vaccines against Her2/neu expressing tumors

artículo científico publicado en 2009

NK cells control breast cancer and related cancer stem cell hematological spread

artículo científico publicado en 2017

Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy

artículo científico publicado en 2019

New approaches to management of multiple myeloma.

artículo científico publicado en 2014

Novel insights into Notum and glypicans regulation in colorectal cancer

artículo científico publicado en 2015

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

article by Raffaele A. Calogero et al published 20 February 2008 in Cancer Immunology, Immunotherapy

Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe binding αv β3 integrins.

artículo científico publicado en 2013

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

artículo científico publicado en 2008

PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy.

artículo científico publicado en 2003

Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma

artículo científico publicado en 2012

Preclinical vaccines against mammary carcinoma

artículo científico

Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients

artículo científico publicado en 2007

Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients

artículo científico publicado en 2011

Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

artículo científico publicado en 2016

Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity

artículo científico publicado en 2016

Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain.

artículo científico publicado en 2008

Recent Advances in Cancer Immunotherapy with an Emphasis on Vaccines

artículo científico publicado en 2009

Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors 2 and 4

artículo científico publicado en 2013

Requirement for IFN- , CD8+ T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu+ Tumors

artículo científico publicado en 2007

Role of consolidation/maintenance therapy in multiple myeloma.

artículo científico

Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice

artículo científico publicado en 2008

Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013

article

Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma

artículo científico publicado en 2009

Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene

artículo científico publicado en 2010

State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues?

artículo científico publicado en 2013

State-of-the-art fusion-finder algorithms sensitivity and specificity

artículo científico publicado en 2013

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy

artículo científico publicado en 2011

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.

artículo científico publicado en 2018

Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma.

artículo científico publicado en 2004

Survival of the fittest or best adapted: HLA-dependent tumor development

artículo científico publicado en 2010

Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers

artículo científico publicado en 2013

Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells.

artículo científico publicado en 2015

Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant

artículo científico publicado en 2005

The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24-26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy

artículo científico publicado en 2015

The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis.

artículo científico publicado en 2017

The Promise of Preventive Cancer Vaccines

artículo científico publicado en 2015

The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.

artículo científico publicado en 2005

The importance of comparative oncology in translational medicine

artículo científico publicado en 2014

The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells

artículo científico publicado en 2013

The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2(+) mammary cancer.

artículo científico publicado en 2015

The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents

artículo científico

The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries

scientific article published on 16 March 2017

Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.

artículo científico publicado en 2007

Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota

artículo científico publicado en 2020

Vaccination for treatment and prevention of cancer in animal models.

artículo científico publicado en 2006

Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.

artículo científico publicado en 2013

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

artículo científico publicado en 2014

Vaccines and other immunological approaches for cancer immunoprevention

artículo científico publicado en 2011

Vaccines for tumour prevention

artículo científico publicado en 2006

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines

artículo científico publicado en 2020

Xenogene vaccination in the therapy of cancer

artículo científico

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

artículo científico publicado en 2010

miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.

artículo científico publicado en 2013

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

artículo científico publicado en 2006

p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity

artículo científico publicado en 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda